Consistent with FDPS inhibition as its mechanism of action, 7 exhibited potent inhibitory activity for RAP1A prenylation in tumor cells (3,200-fold more active than zoledronic acid) and tumor cell growth43 (184-fold more potent than zoledronic acid). Here, RAP1A is linked to neoplasm.